History of Present Illness: 58M w multiple medical comorbidities xferred from OSH w abdominal pain and diarrhea x 4 days.
At OSH patient was hemodynamically stable though CT A/P showed contained ascending colon perforation with severe associated inflammation.
Also demonstrated WBC to 14 and blood glucose in 400s.
Tobacco: Current 0.5 ppd, long time smoker; EtOH: denies; Recreational drugs: denies   Family History: Mother - EtOH abuse, CAD, Lung Ca; Father - EtOH abuse; Brother - Type 2 diabetes   Physical Exam: On presentation to [**Hospital1 18**]:  VS: 99.6    90    128/47    16    98%RA GEN: WD, WN middle aged M in NAD HEENT: NCAT, EOMI, anicteric; +NGT CV: RRR PULM: CTA B/L w no W/R/R, no respiratory distress ABD: +involuntary guarding, severe diffuse tenderness to light palpation (R>L), minimally distended, no mass, no hernia PELVIS: normal rectal tone, prostate WNL, black stool - guaiac POSITIVE EXT: WWP, no CCE, 2+ B/L radial/DP/PT NEURO: A&Ox3, no focal neurologic deficits DERM: no rashes/lesions/ulcers PSYCH: normal judgment/insight, normal memory, normal mood/affect   Pertinent Results: LABORATORIES: Admit: [**2161-9-1**] 06:20AM BLOOD WBC-10.3 RBC-4.14* Hgb-9.4* Hct-30.3* MCV-73* MCH-22.6* MCHC-30.9* RDW-22.4* Plt Ct-294 [**2161-9-1**] 06:20AM BLOOD PT-14.7* PTT-34.5 INR(PT)-1.3* [**2161-9-1**] 06:20AM BLOOD Glucose-400* UreaN-20 Creat-1.3* Na-128* K-3.7 Cl-91* HCO3-23 AnGap-18 [**2161-9-1**] 06:20AM BLOOD ALT-15 AST-12 CK(CPK)-59 AlkPhos-133* TotBili-1.2 [**2161-9-1**] 06:20AM BLOOD Albumin-3.4* Calcium-8.4 Phos-3.4 Mg-1.9  Discharge:  IMAGING: CT A/P [**9-1**]: 1.
FIRST/SECOND MORPHOLOGY; Isolated from only one set in the previous five days  PATHOLOGY: Specimen Type:  Right hemicolectomy with portion of transverse colon.
Given patient's extensive medical comorbidities and anti-coagulation (on plavix) he was initially admitted to the TSICU with a plan for observation and serial abdominal exams.
Over the course of [**9-1**] patient's abdominal exam continued to worsen and decision was made to bring patient to the OR [**9-1**] PM for exploratory laparotomy.
On [**9-7**] his QTc interval was noted to be 464 ms (from 448 preoperatively on [**9-1**]) and his standing haldol was discontinued.
On [**9-8**] a follow up ECG showed a QTc of 443 ms. [**First Name (Titles) **] [**Last Name (Titles) 19206**] were routinely checked and repleted as needed.
The patient was stable from a cardiovascular standpoint; vital signs were routinely monitored and he remained on telemetry monitoring.
The patient was stable from a pulmonary standpoint; vital signs were routinely monitored.
An NGT was in place postoperatively and was discontinued [**9-3**].
Also of note, his creatinine was elevated to 1.6 at highest on [**9-5**].
After discontinuation of vancomycin, his creatinine trended downward appropriately to 1.2 on [**9-9**].
Pathology returned from colonic resection demonstrated T4N2 colonic mucinous adenoCA w signet ring features.
Endo: Given his history of IDDM, his blood sugars were monitored closely throughout his hospitalization.
[**Initials (NamePattern4) **] [**Last Name (NamePattern4) **] consult was obtained who recommended [**Hospital1 **] standing NPH and a sliding scale.
By the day of discharge, his blood glucose levels were controlled on the insulin regimen recommended by [**Last Name (un) **].
His pain was well controlled and his blood glucose levels were stable.
Medications on Admission: [**Last Name (un) 1724**] (compliance questionable): ASA 81', plavix 75', Metoprolol succinate 12.5', lisinopril 2.5', lasix 40 QHS, spironolactone 12.5', ezetimibe 10', simvastatin 20 QHS, combivent 18-103 2 INH QID prn, Novolin-N 20u QAM, 7u QPM, Insulin aspart 20u QAC prn, FeSO4 300(60)''', acetaminophen 325 Q6H prn, fluticasone 50 NAS   Discharge Medications: 1. fluticasone 50 mcg/Actuation Spray, Suspension Sig: Two (2) Spray Nasal DAILY (Daily).
